IP-Cure-B annual meeting
📢 EUCLID (EUropean CLInical Trials Platform & Development) / UMS54 MART Methods and Applied Research for Trials is attending today, 20 November 2025, the annual meeting of the IP-Cure-B project, a European programme coordinated by Inserm and Pr Fabien Zoulim, and funded by Horizon 2020, dedicated to developing new immunomodulatory approaches to improve the management […]